Antimicrobial agents play a pivotal role in combating infectious diseases, offering a crucial line of defense against harmful microorganisms. Antibiotics, in particular, are substances derived from living organisms or synthesized chemically, designed to inhibit the growth of bacteria or destroy them altogether. They target specific cellular components or processes, disrupting bacterial functions without harming human cells. In the realm of antiviral agents, drugs like protease inhibitors and nucleoside analogs thwart the replication of viruses by targeting key enzymes. Antifungal agents, on the other hand, combat fungal infections by disrupting cell membrane synthesis or inhibiting essential enzymes. Parasitic infections are addressed through antiparasitic agents, targeting specific metabolic pathways in parasites. The emergence of antimicrobial resistance poses a significant challenge, urging the continuous exploration of novel agents and alternative therapeutic strategies. Research in this field focuses on developing innovative antimicrobial compounds, exploring combination therapies, and understanding the mechanisms behind resistance.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation